Salvador Moncada

151.2k total citations · 65 hit papers
621 papers, 123.8k citations indexed

About

Salvador Moncada is a scholar working on Physiology, Biochemistry and Pharmacology. According to data from OpenAlex, Salvador Moncada has authored 621 papers receiving a total of 123.8k indexed citations (citations by other indexed papers that have themselves been cited), including 316 papers in Physiology, 179 papers in Biochemistry and 144 papers in Pharmacology. Recurrent topics in Salvador Moncada's work include Nitric Oxide and Endothelin Effects (286 papers), Eicosanoids and Hypertension Pharmacology (172 papers) and Inflammatory mediators and NSAID effects (132 papers). Salvador Moncada is often cited by papers focused on Nitric Oxide and Endothelin Effects (286 papers), Eicosanoids and Hypertension Pharmacology (172 papers) and Inflammatory mediators and NSAID effects (132 papers). Salvador Moncada collaborates with scholars based in United Kingdom, Spain and United States. Salvador Moncada's co-authors include Richard Palmer, E.A. Higgs, John R. Vane, Anthony G. Ferrige, Marek W. Radomski, Richard G. Knowles, Franklin H. Epstein, Ryszard J. Gryglewski, Daryl D. Rees and D. Ashton and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Salvador Moncada

614 papers receiving 118.2k citations

Hit Papers

Nitric oxide: physiology,... 1971 2026 1989 2007 1991 1987 1993 1988 1976 4.0k 8.0k 12.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Nitric oxide: physiology, pathophysiology, and pharmacology.
    1991 13.5k citations Salvador Moncada, Richard Palmer et al. profile →
  2. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
    1987 8.6k citations Richard Palmer, Salvador Moncada et al. profile →
  3. The L-Arginine-Nitric Oxide Pathway
    1993 5.5k citations Salvador Moncada et al. profile →
  4. Vascular endothelial cells synthesize nitric oxide from L-arginine
    1988 3.9k citations Richard Palmer, Salvador Moncada et al. profile →
  5. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation
    1976 2.8k citations Salvador Moncada et al. profile →
  6. Nitric oxide synthases in mammals
    1994 2.3k citations Salvador Moncada et al. profile →
  7. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor
    1986 2.0k citations Richard Palmer, Salvador Moncada et al. profile →
  8. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo
    1990 1.7k citations Daryl D. Rees, Richard Palmer et al. British Journal of Pharmacology profile →
  9. Role of endothelium-derived nitric oxide in the regulation of blood pressure.
    1989 1.5k citations Daryl D. Rees, Richard Palmer et al. Proceedings of the National Academy of Sciences profile →
  10. EFFECTS OF ENDOTHELIUM-DERIVED NITRIC OXIDE ON PERIPHERAL ARTERIOLAR TONE IN MAN
    1989 1.3k citations Salvador Moncada et al. profile →
  11. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin.
    1978 1.3k citations Salvador Moncada et al. profile →
  12. Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase.
    1989 1.3k citations Miriam Palacios‐Callender, Richard Palmer et al. Proceedings of the National Academy of Sciences profile →
  13. ENDOGENOUS NITRIC OXIDE INHIBITS HUMAN PLATELET ADHESION TO VASCULAR ENDOTHELIUM
    1987 1.2k citations Richard Palmer, Salvador Moncada et al. profile →
  14. L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation
    1988 1.1k citations Richard Palmer, Daryl D. Rees et al. Biochemical and Biophysical Research Communications profile →
  15. Altered immune responses in mice lacking inducible nitric oxide synthase
    1995 1.1k citations Salvador Moncada et al. profile →
  16. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide
    1994 1.0k citations Salvador Moncada et al. profile →
  17. Mitochondrial Biogenesis in Mammals: The Role of Endogenous Nitric Oxide
    2003 1.0k citations Enzo Nisoli, Emilio Clementi et al. Science profile →
  18. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation.
    1990 1.0k citations Richard Palmer, Salvador Moncada et al. Proceedings of the National Academy of Sciences profile →
  19. The anti‐aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide
    1987 932 citations Richard Palmer, Salvador Moncada et al. British Journal of Pharmacology profile →
  20. Arachidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel Walls
    1979 913 citations Salvador Moncada et al. profile →
  21. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells.
    1990 909 citations Richard Palmer, Salvador Moncada et al. Proceedings of the National Academy of Sciences profile →
  22. Calorie Restriction Promotes Mitochondrial Biogenesis by Inducing the Expression of eNOS
    2005 903 citations Enzo Nisoli, Cristina Tonello et al. Science profile →
  23. Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides
    1976 815 citations Salvador Moncada et al. profile →
  24. Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregation
    1976 789 citations Salvador Moncada et al. profile →
  25. NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices
    1989 785 citations Richard Palmer, Salvador Moncada et al. profile →
  26. A specific inhibitor of nitric oxide formation from l‐arginine attenuates endothelium‐dependent relaxation
    1989 745 citations Daryl D. Rees, Richard Palmer et al. British Journal of Pharmacology profile →
  27. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans
    1991 744 citations Antonio Leone, Salvador Moncada et al. Biochemical and Biophysical Research Communications profile →
  28. Indomethacin and Aspirin abolish Prostaglandin Release from the Spleen
    1971 744 citations Salvador Moncada et al. profile →
  29. Persistent inhibition of cell respiration by nitric oxide: Crucial role ofS-nitrosylation of mitochondrial complex I and protective action of glutathione
    1998 710 citations Emilio Clementi, Salvador Moncada et al. Proceedings of the National Academy of Sciences profile →
  30. HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATION
    1977 690 citations Salvador Moncada et al. profile →
  31. The discovery of nitric oxide and its role in vascular biology
    2006 683 citations Salvador Moncada et al. British Journal of Pharmacology profile →
  32. Comparative pharmacology of endothelium‐derived relaxing factor, nitric oxide and prostacyclin in platelets
    1987 670 citations Richard Palmer, Salvador Moncada et al. British Journal of Pharmacology profile →
  33. Roles of nitric oxide in tumor growth.
    1995 664 citations Salvador Moncada et al. Proceedings of the National Academy of Sciences profile →
  34. Molecular mechanisms and therapeutic strategies related to nitric oxide
    1995 658 citations Salvador Moncada et al. profile →
  35. The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C–Cdh1
    2009 647 citations Ángel Herrero-Méndez, Ángeles Almeida et al. Nature Cell Biology profile →
  36. Does nitric oxide modulate mitochondrial energy generation and apoptosis?
    2002 646 citations Salvador Moncada et al. profile →
  37. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from l -arginine.
    1990 631 citations Richard Palmer, Salvador Moncada et al. profile →
  38. Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide
    1992 619 citations Salvador Moncada et al. profile →
  39. Redistribution of Intracellular Oxygen in Hypoxia by Nitric Oxide: Effect on HIF1α
    2003 614 citations Thilo Hagen, Francis Lam et al. Science profile →
  40. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium
    1987 600 citations Richard Palmer, Salvador Moncada et al. Biochemical and Biophysical Research Communications profile →
  41. The chemical structure of prostaglandin X (prostacyclin)
    1976 599 citations Salvador Moncada et al. profile →
  42. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases.
    1992 598 citations Richard Palmer, Salvador Moncada et al. profile →
  43. Endogenous nitric oxide: physiology, pathology and clinical relevance
    1991 597 citations Salvador Moncada et al. profile →
  44. The 1991 Ulf von Euler Lecture:Thel‐arginine: nitric oxide pathway
    1992 575 citations Salvador Moncada profile →
  45. Widespread tissue distribution, species distribution and changes in activity of Ca2+‐dependent and Ca2+‐independent nitric oxide synthases
    1991 562 citations Salvador Moncada et al. profile →
  46. Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium
    1977 532 citations Salvador Moncada et al. profile →
  47. Nitric oxide synthase activity in human breast cancer
    1995 529 citations Salvador Moncada et al. profile →
  48. Induction and potential biological relevance of a Ca2+‐independent nitric oxide synthase in the myocardium
    1992 519 citations Salvador Moncada et al. British Journal of Pharmacology profile →
  49. Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets
    1977 515 citations Salvador Moncada et al. profile →
  50. INHIBITION OF NITRIC OXIDE SYNTHASE AS A POTENTIAL THERAPEUTIC TARGET
    1999 509 citations Salvador Moncada et al. profile →
  51. Hyperdynamic circulation in cirrhosis: a role for nitric oxide?
    1991 496 citations Salvador Moncada et al. profile →
  52. A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells
    1989 495 citations Richard Palmer, Salvador Moncada Biochemical and Biophysical Research Communications profile →
  53. A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation
    1976 491 citations Salvador Moncada et al. profile →
  54. Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides
    1976 425 citations Salvador Moncada et al. profile →
  55. UNSTABLE METABOLITES OF ARACHIDONIC ACID AND THEIR ROLE IN HAEMOSTASIS AND THROMBOSIS
    1978 348 citations Salvador Moncada et al. profile →
  56. Prostacyclin (PGX) is the endogeneous metabolite responsible for relaxation of coronary arteries induced by arachidonic acid
    1977 339 citations Salvador Moncada et al. profile →
  57. Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa
    1980 315 citations Brendan J.R. Whittle, Salvador Moncada et al. profile →
  58. Prostacyclin is a circulating hormone
    1978 292 citations Salvador Moncada et al. profile →
  59. Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species
    1978 284 citations Brendan J.R. Whittle, Salvador Moncada et al. profile →
  60. The Third Version of the Copenhagen Psychosocial Questionnaire
    2019 280 citations Hermann Burr, Hanne Berthelsen et al. Safety and Health at Work profile →
  61. Prostaglandins, Aspirin-like Drugs and the Oedema of Inflammation
    1973 251 citations Salvador Moncada et al. profile →
  62. Prostaglandins and the mechanism of analgesia produced by aspirin‐like drugs
    1973 249 citations Salvador Moncada et al. British Journal of Pharmacology profile →
  63. : A selective inhibitor of thromboxane synthetase
    1977 247 citations Salvador Moncada et al. profile →
  64. Further studies on the enzymatic conversion of prostaglandin endoperoxide into prostacyclin by porcine aorta microsomes
    1978 240 citations Salvador Moncada et al. profile →
  65. COMPARISON OF THE VASODEPRESSOR EFFECTS OF PROSTACYCLIN AND 6‐OXO‐PROSTAGLANDIN F1α WITH THOSE OF PROSTAGLANDIN E2 IN RATS AND RABBITS
    1978 222 citations Salvador Moncada et al. British Journal of Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Salvador Moncada United Kingdom 161 65.1k 26.7k 26.5k 22.9k 13.4k 621 123.8k
Bruce M. Spiegelman United States 172 71.2k 1.1× 73.0k 2.7× 11.3k 0.4× 9.5k 0.4× 5.6k 0.4× 350 137.4k
John R. Vane United Kingdom 113 18.4k 0.3× 13.2k 0.5× 12.3k 0.5× 11.9k 0.5× 24.7k 1.8× 468 63.3k
Richard Palmer United Kingdom 77 34.6k 0.5× 10.5k 0.4× 13.2k 0.5× 10.0k 0.4× 2.4k 0.2× 222 57.9k
Gerald I. Shulman United States 162 44.9k 0.7× 49.7k 1.9× 8.4k 0.3× 6.9k 0.3× 3.2k 0.2× 619 106.8k
Peter J. Barnes United Kingdom 182 78.5k 1.2× 30.0k 1.1× 5.8k 0.2× 2.7k 0.1× 5.0k 0.4× 1.8k 153.7k
Barry Halliwell United Kingdom 176 20.5k 0.3× 45.3k 1.7× 2.6k 0.1× 9.5k 0.4× 7.8k 0.6× 736 138.6k
Bart Staels France 147 18.2k 0.3× 41.5k 1.6× 6.0k 0.2× 5.8k 0.3× 5.0k 0.4× 789 78.9k
David G. Harrison United States 134 23.3k 0.4× 14.1k 0.5× 20.4k 0.8× 7.3k 0.3× 2.3k 0.2× 400 60.5k
Garret A. FitzGerald United States 115 9.0k 0.1× 11.4k 0.4× 9.9k 0.4× 7.9k 0.3× 14.4k 1.1× 488 50.4k
Ronald M. Evans United States 187 20.1k 0.3× 96.0k 3.6× 3.1k 0.1× 5.1k 0.2× 5.3k 0.4× 629 148.1k

Countries citing papers authored by Salvador Moncada

Since Specialization
Citations

This map shows the geographic impact of Salvador Moncada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salvador Moncada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salvador Moncada more than expected).

Fields of papers citing papers by Salvador Moncada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salvador Moncada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salvador Moncada. The network helps show where Salvador Moncada may publish in the future.

Co-authorship network of co-authors of Salvador Moncada

This figure shows the co-authorship network connecting the top 25 collaborators of Salvador Moncada. A scholar is included among the top collaborators of Salvador Moncada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salvador Moncada. Salvador Moncada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Llorens, Clara, et al.. (2022). Mental health inequalities in times of crisis: evolution between 2005 and 2021 among the Spanish salaried population. Journal of Epidemiology & Community Health. 77(1). 38–43. 5 indexed citations
2.
Burr, Hermann, Hanne Berthelsen, Salvador Moncada, et al.. (2019). The Third Version of the Copenhagen Psychosocial Questionnaire. Safety and Health at Work. 10(4). 482–503. 280 indexed citations breakdown →
3.
Colombo, Sergio L., et al.. (2010). Anaphase-promoting complex/cyclosome-Cdh1 coordinates glycolysis and glutaminolysis with transition to S phase in human T lymphocytes. Proceedings of the National Academy of Sciences. 107(44). 18868–18873. 96 indexed citations
4.
Herrero-Méndez, Ángel, Ángeles Almeida, Emilio Fernández, et al.. (2009). The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C–Cdh1. Nature Cell Biology. 11(6). 747–752. 647 indexed citations breakdown →
5.
Almeida, Ángeles, Juan P. Bolaños, & Salvador Moncada. (2009). E3 ubiquitin ligase APC/C-Cdh1 accounts for the Warburg effect by linking glycolysis to cell proliferation. Proceedings of the National Academy of Sciences. 107(2). 738–741. 134 indexed citations
6.
Palacios‐Callender, Miriam, et al.. (2007). Cytochrome c oxidase regulates endogenous nitric oxide availability in respiring cells: A possible explanation for hypoxic vasodilation. Proceedings of the National Academy of Sciences. 104(47). 18508–18513. 69 indexed citations
7.
Quintero, Marisol, Sergio L. Colombo, Andrew Godfrey, & Salvador Moncada. (2006). Mitochondria as signaling organelles in the vascular endothelium. Proceedings of the National Academy of Sciences. 103(14). 5379–5384. 293 indexed citations
8.
D’Amico, Gabriela, Francis Lam, Thilo Hagen, & Salvador Moncada. (2006). Inhibition of cellular respiration by endogenously produced carbon monoxide. Journal of Cell Science. 119(11). 2291–2298. 105 indexed citations
9.
Nisoli, Enzo, Emilio Clementi, Clara Paolucci, et al.. (2003). Mitochondrial Biogenesis in Mammals: The Role of Endogenous Nitric Oxide. Science. 299(5608). 896–899. 1011 indexed citations breakdown →
10.
Moncada, Salvador, et al.. (2002). Characterization of the non‐nitrergic NANC relaxation responses in the rabbit vaginal wall. British Journal of Pharmacology. 135(2). 546–554. 40 indexed citations
11.
Rees, Rowland, et al.. (2001). Y‐27632, an inhibitor of Rho‐kinase, antagonizes noradrenergic contractions in the rabbit and human penile corpus cavernosum. British Journal of Pharmacology. 133(4). 455–458. 88 indexed citations
12.
Moncada, Salvador. (1999). Endothelium-derived nitric oxide. UCL Discovery (University College London). 14 indexed citations
13.
Lamas, Santiago, Dolores Pérez‐Sala, & Salvador Moncada. (1998). Nitric oxide: from discovery to the clinic. Trends in Pharmacological Sciences. 19(11). 436–438. 48 indexed citations
14.
Belder, Adam de & Salvador Moncada. (1995). Cardiomyopathy: a role for nitric oxide?. International Journal of Cardiology. 50(3). 263–268. 14 indexed citations
15.
Petros, Andy, Gavin P. Lamb, Antonio Leone, et al.. (1994). Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovascular Research. 28(1). 34–39. 388 indexed citations
16.
Ialenti, Armando, Salvador Moncada, & Massimo Di Rosa. (1993). Modulation of adjuvant arthritis by endogenous nitric oxide. British Journal of Pharmacology. 110(2). 701–706. 251 indexed citations
17.
López-Belmonte, Juan Luis, Brendan J.R. Whittle, & Salvador Moncada. (1993). The actions of nitric oxide donors in the prevention or induction of injury to the rat gastric mucosa. British Journal of Pharmacology. 108(1). 73–78. 180 indexed citations
18.
McCall, Thérèse, Richard Palmer, & Salvador Moncada. (1992). Interleukin-8 inhibits the induction of nitric oxide synthase in rat peritoneal neutrophils. Biochemical and Biophysical Research Communications. 186(2). 680–685. 56 indexed citations
19.
Moncada, Salvador. (1992). Enzymology, biochemistry and immunology. 9 indexed citations
20.
Palmer, Richard, Daryl D. Rees, David Ashton, & Salvador Moncada. (1988). L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochemical and Biophysical Research Communications. 153(3). 1251–1256. 1094 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bruce M. Spiegelman Breakdown of academic impact, for papers by John R. Vane Breakdown of academic impact, for papers by Richard Palmer Breakdown of academic impact, for papers by Gerald I. Shulman Breakdown of academic impact, for papers by Peter J. Barnes Breakdown of academic impact, for papers by Barry Halliwell Breakdown of academic impact, for papers by Bart Staels Breakdown of academic impact, for papers by David G. Harrison Breakdown of academic impact, for papers by Garret A. FitzGerald Breakdown of academic impact, for papers by Ronald M. Evans
Rankless by CCL
2026